|
|
Experience of Professor Chen Zhaojun in the treatment of early stage knee osteoarthritis with Chenshi Suhong Decoction |
HAN Jinglu1 DENG Pin1 LIANG Huan1 SUN Xiaojie1 WANG Shulong1 HUANG Zhichao1 LI Dongxiao1 CHEN Zhaojun2 |
1.The Third Clinical Medical College, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Department of Hand and Foot Surgery, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China |
|
|
Abstract To introduce Professor Chen Zhaojun’s clinical experience in the treatment of early stage knee osteoarthritis with Chenshi Suhong Decoction. Professor Chen believes that this disease is caused by the combination of three factors of kidney deficiency, cold dampness and blood stasis. Kidney deficiency leads to joint dystrophy, followed by internal or external attack of cold dampness, resulting in poor blood circulation and blood stasis, which blocks the channels, and further aggravates kidney deficiency and cold dampness, and so the three methods of tonifying the kidney, dispersing cold dampness and activating blood should be used as the treatment principle. Professor Chen attaches importance to the application of external treatment, and believes that external washing of traditional Chinese medicine has the dual effects of efficacy and physiotherapy, which can directly treat the disease and take effect quickly. In clinic, Chenshi Suhong Decoction is used for external washing to treat this disease, which can tonify the kidney and bones, disperse cold and dehumidification, activate blood circulation and relieve pain with the combination of various drugs, and the curative effect is reliable.
|
|
|
|
|
[1] Dziedzic KS,Healey EL,Porcheret M,et al. Implementing the NICE osteoarthritis guidelines:a mixed methods study and cluster randomised trial of a model osteoarthritis consultation in primary care-the Management of OsteoArthritis In Consultations (MOSAICS) study protocol [J]. Implement Sci,2014,9:95.
[2] Tang X,Wang S,Zhan S,et al. The prevalence of symptomatic knee osteoarthritis in China:results from the China health and retirement longitudinal study [J]. Arthritis Rheumatol,2016,68(3):648-653.
[3] 陆艳红,石晓兵.膝骨关节炎国内外流行病学研究现状及进展[J].中国中医骨伤科杂志,2012,20(6):81-84.
[4] 陈卫衡.膝骨关节炎中医诊疗指南(2020年版)[J].中医正骨,2020,32(10):1-14.
[5] 仝小林.态靶医学——中医未来发展之路[J].中国中西医结合杂志,2021,41(1):16-18.
[6] 庞坚,罗明江,曹月龙,等.刍论膝骨关节炎“本痿标痹,痹痿并存”[J].上海中医药杂志,2013,47(3):25-26.
[7] 汪小健,李少广,王彭禾,等.基于“髓系骨病”理论论治膝骨关节炎[J].中华中医药杂志,2021,36(11):6500-6503.
[8] 陈李专,陈斌,林安阳,等.膝骨关节炎中西医疗法的临床研究进展[J].辽宁中医杂志,2020,47(2):203-206.
[9] 耿运玲,吴圣贤,杜雅薇.试述寒生引病[J].环球中医药,2020,13(3):488-490.
[10] 陈美佳,徐晓娟,田雪梅.五大川派中医对湿之认识与治疗的撷菁[J].湖北中医杂志,2019,41(7):53-54.
[11] 姜洪顺,毛晓晖,金盛.温络疗痹汤联合驱寒化瘀贴治疗寒湿痹阻型膝骨关节炎效果观察[J].中国乡村医药,2022,29(8):27-28.
[12] 毛国庶,张德志,吴坚.中医综合疗法在瘀血阻滞证型膝骨性关节炎中的疗效[J].中医临床研究,2021,13(16):106-108.
[13] 许成燕,陈军香,王教明,等.中国人群膝骨关节炎危险因素的Meta分析[J].中国循证医学杂志,2021,21(7):772-778.
[14] 张志芳,麻春杰,米裕青,等.米子良从瘀论治痹证临证思路[J].中医杂志,2019,60(10):823-826.
[15] 陈庭瑞,杨东辉,陈超.中药熏洗联合玻璃酸钠注射液治疗膝骨关节炎临床研究[J].新中医,2021,53(21):121- 124.
[16] 袁云东,王艳君,齐立卿.灵枢开阖针法治疗寒湿痹阻型膝骨关节炎临床效果[J].中国医药导报,2021,18(12):98-102.
[17] 郑彩杏,李花,刘旺华,等.痰、瘀异同之研究[J].湖南中医杂志,2020,36(3):109-112.
[18] 张丽君,康开彪,王安萍.中医文献中“瘀”“淤”与“瘀血”“淤血”词义辨析[J].西部中医药,2020,33(5):50- 52.
[19] 易腾达,张书萌,王莎莎,等.身痛逐瘀贴辅助治疗瘀血型膝骨关节炎患者的效果[J].中国医药导报,2022,19(9):87-90.
[20] 庞坚,石印玉,曹月龙,等.膝骨关节炎中医观的再认识[J].上海中医药大学学报,2011,25(1):26-28.
[21] 张脉青,朱建华,张桂林.中药熏洗配合针刺对气滞血瘀型膝骨关节炎患者疼痛症状、膝关节功能以及炎症状态的影响[J].中国中医药科技,2022,29(2):224-226.
[22] 周莹莹,张琼,张迁,等.中药外洗法治疗手部湿疹研究概述[J].陕西中医,2022,43(2):265-268.
[23] 钟炜,林小妹.中药熏洗配合膝关节功能锻炼治疗膝关节骨性关节炎临床疗效观察[J].临床合理用药杂志,2018, 11(1):116-118.
[24] 黄法森,马玉峰,吴俊德,等.苏红汤联合艾瑞昔布片治疗膝关节骨性关节炎[J].吉林中医药,2020,40(10):1327- 1330.
[25] 郭珈宜,李峰,冯亦冉.重视膝骨关节炎中医诊疗,科学选择中医非药物疗法——《膝骨关节炎中医诊疗指南(2020年版)》解读[J].中医正骨,2022,34(4):1-3.
[26] 徐国敏.祛痹方内服联合散寒镇痛方穴位贴敷治疗膝骨关节炎寒湿阻络证的临床疗效[J].临床合理用药杂志,2021,14(33):139-141.
[27] 李福民,李丰林,蒋自乐,等.自制“活血通络膏”联合玻璃酸钠治疗风寒湿痹型膝痹病(膝骨关节炎)的临床疗效[J].西部中医药,2021,34(7):108-111.
[28] Cooper C,Chapurlat R,Al-Daghri N,et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis:what does the literature say? [J]. Drugs Aging,2019,36(Suppl 1):15-24.
[29] 徐蓉贞,王柳清,卢建新,等.老年人使用非甾体类抗炎药的安全性及注意事项[J].中国全科医学,2019,22(5):506-510.
|
|
|
|